The global market for fluoroscopy and mobile C-arms generated $1.69 billion in revenue in 2012 and will grow at a compound annual growth rate of just 3% to reach $2.08 billion in 2019, according to a report from Transparency Market Research.
Increasing demand for interventional radiology operations is expected to contribute to growth, along with other factors such as a higher number of orthopedic surgeries due to sports injuries and a geriatric population, technology developments, and an increase in the number of hospitals, Transparency said.
While fluoroscopy devices made up the largest share of the fluoroscopy and mobile C-arm market in terms of revenue in 2012, the mobile C-arm segment is currently dominating the market in terms of volume, according to the company.
In other projections, Transparency said it expects the full-size C-arm market segment to develop at a faster pace from 2013 through 2019, thanks to technical advances and multiple applications.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
